The eukaryotic cell cycle is governed by cyclin-dependent protein kinases (CDKs) whose activities are regulated by cyclins and CDK inhibitors. The protein encoded by this gene is a member of the cyclin family and contains the cyclin box. The encoded protein lacks the protein destabilizing (PEST) sequence that is present in other family members. Transcriptional activation of this gene can be induced by tumor protein p53. Two transcript variants encoding the same protein have been identified for this gene.
^ abcZhao, Lili; Samuels Tina; Winckler Sarah; Korgaonkar Chandrashekhar; Tompkins Van; Horne Mary C; Quelle Dawn E (Jan 2003). "Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways". Mol. Cancer Res. (United States) 1 (3): 195–206. ISSN1541-7786. PMID12556559.
Horne MC, Goolsby GL, Donaldson KL, et al. (1996). "Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression.". J. Biol. Chem.271 (11): 6050–61. doi:10.1074/jbc.271.11.6050. PMID8626390.
Kato MV (1999). "The mechanisms of death of an erythroleukemic cell line by p53: involvement of the microtubule and mitochondria.". Leuk. Lymphoma33 (1-2): 181–6. doi:10.3109/10428199909093740. PMID10194136.
Reimer CL, Borras AM, Kurdistani SK, et al. (1999). "Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells.". J. Biol. Chem.274 (16): 11022–9. doi:10.1074/jbc.274.16.11022. PMID10196184.
Bennin DA, Don AS, Brake T, et al. (2002). "Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest.". J. Biol. Chem.277 (30): 27449–67. doi:10.1074/jbc.M111693200. PMID11956189.
Jordan-Sciutto KL, Morgan K, Bowser R (1999). "Increased Cyclin G1 Immunoreactivity During Alzheimer's Disease.". Journal of Alzheimer's disease : JAD1 (6): 409–417. PMID12214116.
Zhao L, Samuels T, Winckler S, et al. (2003). "Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.". Mol. Cancer Res.1 (3): 195–206. PMID12556559.
Baek WK, Kim D, Jung N, et al. (2003). "Increased expression of cyclin G1 in leiomyoma compared with normal myometrium.". Am. J. Obstet. Gynecol.188 (3): 634–9. doi:10.1067/mob.2003.140. PMID12634633.
Li JQ, Kubo A, Wu F, et al. (2003). "Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes.". Int. J. Oncol.22 (5): 1101–10. doi:10.3892/ijo.22.5.1101. PMID12684677.
Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.
Seo HR, Lee DH, Lee HJ, et al. (2006). "Cyclin G1 overcomes radiation-induced G2 arrest and increases cell death through transcriptional activation of cyclin B1.". Cell Death Differ.13 (9): 1475–84. doi:10.1038/sj.cdd.4401822. PMID16322753.
Gramantieri L, Ferracin M, Fornari F, et al. (2007). "Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.". Cancer Res.67 (13): 6092–9. doi:10.1158/0008-5472.CAN-06-4607. PMID17616664.